Physician profile
Maritza Cotto
NPI 1215034848
$2,961.43
in general payments reported to CMS, 2019-2025
26 companies · $449 in 2025
The $449 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $182 · 2021: $84.91 · 2022: $460 · 2023: $601 · 2024: $689 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,738.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $492.74 | 2022-2025 | (5044) Mcot, Extended Holter, Mcot |
| Amgen INC. | $466.87 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $458.46 | 2019-2025 | |
| Pfizer INC. | $390.22 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $230.50 | 2020-2025 | Lifevest |
| Cvrx, INC. | $110.57 | 2024-2025 | Barostim Neo System |
| Boston Scientific Corporation | $88.72 | 2019-2024 | Watchman Access System, Bodyguardian |
| Kestra Medical Technology Services, INC. | $83.12 | 2022 | |
| Merck Sharp & Dohme LLC | $81.01 | 2022-2025 | Verquvo |
| Ge Healthcare | $74.18 | 2022-2023 | |
| Alnylam Pharmaceuticals INC. | $58.34 | 2019-2024 | Amvuttra |
| Regeneron Healthcare Solutions, INC. | $53.28 | 2019 | |
| Janssen Pharmaceuticals, INC | $48.55 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.34 | 2025 | |
| Akcea Therapeutics, INC. | $39.72 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.09 | 2023 | Jardiance |
| Abbott Laboratories | $29.52 | 2019-2020 | |
| Atricure, INC. | $27.55 | 2024 | |
| Change Healthcare Technologies, LLC | $25.35 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $24.80 | 2019-2022 | |
| Medicomp INC | $20.22 | 2025 | Telepatch Cardiac Monitor |
| Watermark Medical, INC. | $19.36 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $14.81 | 2023 | Arcalyst |
| W. L. Gore & Associates, INC. | $14.77 | 2021 | |
| Vifor Pharma, INC. | $14.76 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maritza Cotto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.